Nicholas J. Sarlis

Technik-/Wissenschafts-/F&E-Leiter bei Sellas Life Sciences Group Ltd.

59 Jahre

Health Technology

Consumer Services

Aktive Positionen von Nicholas J. Sarlis

Unternehmen	Position	Beginn	Ende
Sellas Life Sciences Group Ltd. Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland.	Technik-/Wissenschafts-/F&E-Leiter	-	-

Unternehmen	Position	Beginn	Ende
SELLAS LIFE SCIENCES GROUP, INC.	Direktor/Vorstandsmitglied	29.12.2017	-
SELLAS LIFE SCIENCES GROUP, INC.	Technik-/Wissenschafts-/F&E-Leiter	29.12.2017	01.03.2020
INCYTE CORPORATION	Technik-/Wissenschafts-/F&E-Leiter	01.09.2010	01.05.2016
The University of Texas M.D. Anderson Cancer Center The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX.	Corporate Officer/Principal	01.01.2002	01.01.2006
The University of Texas M.D. Anderson Cancer Center The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX.	Corporate Officer/Principal	-	-

National & Kapodistrian University of Athens	Doctorate Degree
University of London	Doctorate Degree

International

Operativ

Chief Tech/Sci/R&D Officer	3
Doctorate Degree	2
Corporate Officer/Principal	2

Sektoral

Health Technology	4
Consumer Services	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
SELLAS LIFE SCIENCES GROUP, INC.	Health Technology
INCYTE CORPORATION	Health Technology

Private Unternehmen	2
Sellas Life Sciences Group Ltd. Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland.	Health Technology
The University of Texas M.D. Anderson Cancer Center The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX.	Consumer Services

Private Unternehmen

Health Technology

Consumer Services